
The US Senate just scored a major victory for America’s drug dealers.
I’m not talking about the “dope boys” pushing nickels and dimes on the corner. I’m talking about the nation’s REAL drug dealers. The big ballers - the major pharmaceutical companies who raked in over $600 billion in global prescription drug spending in 2006.
On May 9, the Senate passed a bill that, according to The New York Times,
…gives the Food and Drug Administration sweeping new power to police drug safety, order changes in drug labels, regulate advertising and restrict the use and distribution of medicines found to pose serious risks to consumers.
While the measure takes small steps in an effort to ease consumer fears about the FDA’s questionable drug approval methods, the bill renewed the government’s deal with the devil that allows drug companies to pay fees that speed up new drug testing, review and approval. The Times quotes Public Citizen’s Health Research Group director Dr. Sidney M. Wolfe as saying, “The bill’s improvements in F.D.A. authority are important but inadequate. The bill would increase collaboration between the agency and the drug industry, by increasing the agency’s reliance on user fees to finance drug reviews.”
The bill also fails to legalize the importation of lower cost drugs from Canada or to cap the rising cost of medicine. In a society that dopes up on legal and illegal substances of many stripes, drug dealers will have a stronger grip on American bodies and wallets thanks to our politicians.
(more…)